Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis

Clinical Immunology

Volumn 149, Issue 1, 2013, Pages 46-54

  Wang, YaoYao ^a   Yang, Yan ^a   Luo, YangYang ^a   Yin, YongXin ^a   Wang, Qing ^a   Li, YaPing ^a   Kanekura, Takuro ^c   Wang, JiuCun ^d   Liang, GongPing ^a,b   Zhao, Ming ^a,b   Lu, QianJin ^a,b   Xiao, Rong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Key Laboratory of Medical Epigenomics   (China)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d FUDAN UNIVERSITY   (China)

Author keywords

Acetylation; B cells; Histone modification; Methylation; Systemic sclerosis

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 7; HISTONE H3; HISTONE H4; MEPREDNISONE; PREDNISONE;

ACETYLATION; ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; MALE; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; SCLERODERMA DISEASE ACTIVITY INDEX; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS;

ACETYLATION; B CELLS; HISTONE MODIFICATION; METHYLATION; SYSTEMIC SCLEROSIS;

ACETYLATION; ADULT; B-LYMPHOCYTES; FEMALE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MALE; METHYLATION; MIDDLE AGED; RNA, MESSENGER; SCLERODERMA, SYSTEMIC;

EID: 84880957062     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.06.006     Document Type: Article

References (37)

1. Broen J.C., Coenen M.J., Radstake T.R. Genetics of systemic sclerosis: an update. Curr. Rheumatol. Rep. 2012, 14:11-21.
2. Cipriani P., Marrelli A., Liakouli V., Di Benedetto P., Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun. Rev. 2011, 10:641-646. (d).
3. Gu Y.S., Kong J., Cheem a G.S., Keen C.L., Wick G., Gershwin M.E. The immunobiology of systemic sclerosis. Semin. Arthritis Rheum. 2008, 38:132-160.
4. Jiang HongYan, Xiao Rong, Lian XiaoRi, Kanekura Takuro, Luo YangYang, Yin YongXing, Zhang GuiYing, Yang Yan, Wang YaoYao, Zhao Ming, QianJin Lu. Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis. Clin. Immunol. 2012, 143:39-44.
5. Lian XiaoRi, Xiao Rong, XinHong Hu., Kanekura Takuro, Jiang HongYan, Li YaPing, Wang YaoYao, Yang Yan, Zhao Ming, QianJin Lu. DNA demethylation of CD40L in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum. 2012, 64:2338-2345.
6. Bosello S., De Luca G., Tolusso B., Lama G., Angelucci C., Sica G., Ferraccioli G. B cells in systemic sclerosis: a possible target for therapy. Autoimmun. Rev. 2011, 10:624-630.
7. Famularo G., Giacomelli R., Alesse E., Cifone M.G., Morrone S., Boirivant M., Danese C., Perego M.A., Santoni A., Tonietti G. Polyclonal B lymphocyte activation in progressive systemic sclerosis. J. Clin. Lab. Immunol. 1989, 29:59-63.
8. Salinas G.F., Braza F., Brouard S., Tak P.P., Baeten D. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. Clin. Immunol. 2013, 146:34-45.
9. Sato S., Fujimoto M., Hasegawa M., Takehara K. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum. 2004, 50:1918-1927.
10. Hasegawa M. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis. J. Dermatol. 2010, 37:3-10.
11. Chizzolini C. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis. Curr. Opin. Rheumatol. 2008, 20:707-712.
12. Wynn T.A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 2004, 4:583-594.
13. Hasegawa M., Hamaguchi Y., Yanaba K., Bouaziz J.D., Uchida J., Fujimoto M., Matsushita T., Matsushita Y., Horikawa M., Komura K., Takehara K., Sato S., Tedder T.F. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am. J. Pathol. 2006, 169:954-966.
14. Daoussis D., Tsamandas A.C., Liossis S.N., Antonopoulos I., Karatza E., Yiannopoulos G., Andonopoulos A.P. B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin. Arthritis Res. Ther. 2012, 14:R145.
15. Lu Q. The critical importance of epigenetics in autoimmunity. J. Autoimmun. 2013, 41:1-5.
16. Yun M., Wu J., Workman J.L., Li B. Readers of histone modifications. Cell Res. 2011, 21:564-578.
17. Wang Z., Zang C., Cui K., Schones D.E., Barski A., Peng W., Zhao K. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009, 138:1019-1031.
18. Lan F., Shi Y. Epigenetic regulation: methylation of histone and non-histone proteins. Sci. China C Life Sci. 2009, 52:311-322.
19. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21:381-395.
20. Ahangarani R.R., Janssens W., Carlier V., Vanderelst L., Vandendriessche T., Chuah M., Jacquemin M., Saint-Remy J.M. Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2. Mol. Ther. 2011, 19:711-722.
21. Lonzetti L.S., Joyal F., Raynauld J.P., Roussin A., Goulet J.R., Rich E., Choquette D., Raymond Y., Senécal J.L. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001, 44:735-736.
22. Shima Y., Kuwahara Y., Murota H., Kitaba S., Kawai M., Hirano T., Arimitsu J., Narazaki M., Hagihara K., Ogata A., Katayama I., Kawase I., Kishimoto T., Tanaka T. The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab. Rheumatology (Oxford) 2010, 49:2408-2412.
23. Hudson M., Steele R., Canadian Scleroderma Research Group (CSRG), Baron M. Update on indices of disease activity in systemic sclerosis. Semin. Arthritis Rheum. 2007, 37:93-98.
24. Liu Z., Mai A., Sun J. Lysine acetylation regulates Bruton's tyrosine kinase in B cell activation. J. Immunol. 2010, 184:244-254.
25. Green M.R., Yoon H., Boss J.M. Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility. J. Immunol. 2006, 177:3865-3873.
26. Gialitakis M., Kretsovali A., Spilianakis C., Kravariti L., Mages J., Hoffmann R., Hatzopoulos A.K., Papamatheakis J. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. Nucleic Acids Res. 2006, 34:765-772.
27. Thomas L.R., Miyashita H., Cobb R.M., Pierce S., Tachibana M., Hobeika E., Reth M., Shinkai Y., Oltz E.M. Functional analysis of histone methyltransferase g9a in B and T lymphocytes. J. Immunol. 2008, 181:485-493.
28. Wang L., Wuerffel R., Feldman S., Khamlichi A.A., Kenter A.L. S region sequence, RNA polymerase II, and histone modifications create chromatin accessibility during class switch recombination. J. Exp. Med. 2009, 1817-1830.
29. Ito K., Yamamura S., Essilfie-Quaye S., Cosio B., Ito M., Barnes P.J., Adcock I.M. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med. 2006, 203:7-13.
30. Takechi S., Adachi M., Nakayama T. Chicken HDAC2 down-regulates IgM light chain gene promoter activity. Biochem. Biophys. Res. Commun. 2002, 299:263-267.
31. Verdin E., Dequiedt F., Kasler H. HDAC7 regulates apoptosis in developing thymocytes. Novartis Found. Symp. 2004, 259:115-129. (discussion 129-31, 163-9).
32. Izzo A., Schneider R. Chatting histone modifications in mammals. Brief. Funct. Genomics 2010, 9:429-443.
33. Hohl M., Wagner M., Reil J.C., Müller S.A., Tauchnitz M., Zimmer A.M., Lehmann L.H., Thiel G., Böhm M., Backs J., Maack C. HDAC4 controls histone methylation in response to elevated cardiac load. J. Clin. Invest. 2013, 123:1359-1370.
34. Puschendorf M., Terranova R., Boutsma E., Mao X., Isono K., Brykczynska U., Kolb C., Otte A.P., Koseki H., Orkin S.H., van Lohuizen M., Peters A.H. PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryos. Nat. Genet. 2008, 40:411-420.
35. Yamane K., Toumazou C., Tsukada Y., Erdjument-Bromage H., Tempst P., Wong J., Zhang Y. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 2006, 125:483-495.
36. Liubchenko G.A., Appleberry H.C., Striebich C.C., Franklin K.E., Derber L.A., Holers V.M., Lyubchenko T. Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes. J. Autoimmun. 2013, 40:111-121.
37. Shirota Y., Yarboro C., Fischer R., Pham T.H., Lipsky P., Illei G.G. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2013, 72:118-128.